Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 744


Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.

Schmidt SM, Schag K, Müller MR, Weck MM, Appel S, Kanz L, Grünebach F, Brossart P.

Blood. 2003 Jul 15;102(2):571-6.


An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.

Hirohashi Y, Torigoe T, Maeda A, Nabeta Y, Kamiguchi K, Sato T, Yoda J, Ikeda H, Hirata K, Yamanaka N, Sato N.

Clin Cancer Res. 2002 Jun;8(6):1731-9.


Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes.

Schag K, Schmidt SM, Müller MR, Weinschenk T, Appel S, Weck MM, Grünebach F, Stevanovic S, Rammensee HG, Brossart P.

Clin Cancer Res. 2004 Jun 1;10(11):3658-66.


Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells.

Zeis M, Siegel S, Wagner A, Schmitz M, Marget M, Kühl-Burmeister R, Adamzik I, Kabelitz D, Dreger P, Schmitz N, Heiser A.

J Immunol. 2003 Jun 1;170(11):5391-7.


Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.

Jenne L, Arrighi JF, Jonuleit H, Saurat JH, Hauser C.

Cancer Res. 2000 Aug 15;60(16):4446-52.


Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells.

Yokoyama Y, Grünebach F, Schmidt SM, Heine A, Häntschel M, Stevanovic S, Rammensee HG, Brossart P.

Clin Cancer Res. 2008 Sep 1;14(17):5503-11. doi: 10.1158/1078-0432.CCR-07-4041.


Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies.

Siegel S, Wagner A, Kabelitz D, Marget M, Coggin J Jr, Barsoum A, Rohrer J, Schmitz N, Zeis M.

Blood. 2003 Dec 15;102(13):4416-23.


Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides.

Schmitz M, Diestelkoetter P, Weigle B, Schmachtenberg F, Stevanovic S, Ockert D, Rammensee HG, Rieber EP.

Cancer Res. 2000 Sep 1;60(17):4845-9.


Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells.

Grünebach F, Erndt S, Häntschel M, Heine A, Brossart P.

Cancer Immunol Immunother. 2008 Oct;57(10):1483-91. doi: 10.1007/s00262-008-0486-5.


Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies.

Gottschalk S, Edwards OL, Sili U, Huls MH, Goltsova T, Davis AR, Heslop HE, Rooney CM.

Blood. 2003 Mar 1;101(5):1905-12.


Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein.

Cho HI, Kim EK, Park SY, Lee SK, Hong YK, Kim TG.

Cancer Lett. 2007 Dec 18;258(2):189-98.


Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.

Valmori D, Liénard D, Waanders G, Rimoldi D, Cerottini JC, Romero P.

Cancer Res. 1997 Feb 15;57(4):735-41.


Dendritic cells with transduced survivin gene induce specific cytotoxic T lymphocytes in human urologic cancer cell lines.

Kikkawa K, Fujii R, Kuramoto T, Mori T, Inagaki T, Kohjimoto Y, Iwahashi M, Yamaue H, Hara I.

Urology. 2009 Jul;74(1):222-8. doi: 10.1016/j.urology.2008.12.045.


[Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66].

Jin S, Wang Y, Wang SJ, Zhang HZ, Li MX, Chen Y, Ge HL.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 Mar;21(2):233-6, 242. Chinese.


Identification of HLA-A*0201-presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies.

Siegel S, Wagner A, Friedrichs B, Wendeler A, Wendel L, Kabelitz D, Steinmann J, Barsoum A, Coggin J, Rohrer J, Dreger P, Schmitz N, Zeis M.

J Immunol. 2006 Jun 1;176(11):6935-44.


Identification and characterization of T-cell epitopes deduced from RGS5, a novel broadly expressed tumor antigen.

Boss CN, Grünebach F, Brauer K, Häntschel M, Mirakaj V, Weinschenk T, Stevanovic S, Rammensee HG, Brossart P.

Clin Cancer Res. 2007 Jun 1;13(11):3347-55.


Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.

Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.

Oncol Rep. 2004 Oct;12(4):725-31.

Items per page

Supplemental Content

Support Center